PEG-interferon α-2b plus ribavirin for treatment of patients with chronic hepatitis C who have previously failed to achieve a sustained virologic response following interferon A or interferon α-2b plus ribavirin therapy.

被引：0
|
作者：
Sulkowski, M
Rothstein, KD
Stein, L
Godofsky, E
Shoultz, D
Hudnall, R
Huff, M
Dieterich, D
机构：
[1] Johns Hopkins Med Inst, Baltimore, MD 21205 USA
[2] Albert Einstein Med Ctr, Philadelphia, PA 19141 USA
[3] Univ Washington, Seattle, WA 98195 USA
[4] PPD Dev, Seattle, WA USA
[5] Hepatitis Resource Network, Tacoma, WA USA
[6] NYU, Sch Med, New York, NY USA
来源：
HEPATOLOGY | 2001年 / 34卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
987
引用
收藏
页码：419A / 419A
页数：1
相关论文
共 50 条
  • [31] Pegylated interferon α2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients
    Moreno, L
    Quereda, C
    Moreno, A
    Perez-Elías, MJ
    Antela, A
    Casado, JL
    Dronda, F
    Mateos, ML
    Bárcena, R
    Moreno, S
    AIDS, 2004, 18 (01) : 67 - 73
  • [32] Interferon Alfacon-1 and Ribavirin Versus Interferon α-2b and Ribavirin in the Treatment of Chronic Hepatitis C
    Maria H. Sjogren
    Robert Sjogren
    Kent Holtzmuller
    Bradley Winston
    Betty Butterfield
    Stanley Drake
    Amber Watts
    Robin Howard
    Milton Smith
    Digestive Diseases and Sciences, 2005, 50 : 727 - 732
  • [33] Effect of interferon α-2b plus ribavirin therapy on incidence of hepatocellular carcinoma in patients with chronic hepatitis
    Kurokawa, Mika
    Hiramatsu, Naoki
    Oze, Tsugiko
    Mochizuki, Kiyoshi
    Yakushijin, Takayuki
    Kurashige, Nao
    Inoue, Yuko
    Igura, Takumi
    Imanaka, Kazuho
    Yamada, Akira
    Oshita, Masahide
    Hagiwara, Hideki
    Mita, Eiji
    Ito, Toshifumi
    Inui, Yoshiaki
    Hijioka, Taizo
    Yoshihara, Harumasa
    Inoue, Atsuo
    Imai, Yasuharu
    Kato, Michio
    Kiso, Shinichi
    Kanto, Tatsuya
    Takehara, Tetsuo
    Kasahara, Akinori
    Hayashi, Norio
    HEPATOLOGY RESEARCH, 2009, 39 (05) : 432 - 438
  • [34] Efficacy and safety of treatment with interferon-α2b plus ribavirin in children with chronic hepatitis C
    Iwona Mozer-Lisewska
    Nature Clinical Practice Gastroenterology & Hepatology, 2006, 3 : 316 - 317
  • [35] Preliminary report:: Efficacy of high dose daily induction interferon α-2b plus ribavirin followed by continuing daily interferon α-2b plus ribavirin in the treatment of hepatitis C.
    King, JW
    Favrot, DR
    Markanday, A
    HEPATOLOGY, 1999, 30 (04) : 629A - 629A
  • [36] A randomized trial of pegylated interferon α-2b plus ribavirin in the retreatment of chronic hepatitis C
    Jacobson, IM
    Gonzalez, SA
    Ahmed, F
    Lebovics, E
    Min, AD
    Bodenheimer, HC
    Esposito, SP
    Brown, RS
    Bräu, N
    Klion, FM
    Tobias, H
    Bini, EJ
    Brodsky, N
    Cerulli, MA
    Aytaman, A
    Gardner, PW
    Geders, JM
    Spivack, JE
    Rahmin, MG
    Berman, DH
    Ehrlich, J
    Russo, MW
    Chait, M
    Rovner, D
    Edlin, BR
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (11): : 2453 - 2462
  • [37] Durability of sustained virologic response in patients with chronic hepatitis C after treatment with interferon α-2b alone or in combination with ribavirin.
    McHutchison, JG
    Davis, GL
    Esteban-Mur, R
    Poynard, T
    Ling, MH
    Garaud, JJ
    Albrecht, J
    HEPATOLOGY, 2001, 34 (04) : 244A - 244A
  • [38] Peg-interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C genotype 4
    Shiha, G.
    Abass, B.
    El-Shenawy, H.
    Zalata, K.
    Attia, M.
    Farouk, D.
    LIVER INTERNATIONAL, 2006, 26 : 79 - 79
  • [39] Ribavirin dosage in patients with HCV genotypes 2 and 3 who completed short therapy with peg-interferon α-2b and ribavirin
    Mangia, A.
    Dalgard, O.
    Minerva, N.
    Verbaan, H.
    Bacca, D.
    Ring-Larsen, H.
    Copetti, M.
    Carretta, V.
    Piazzolla, V.
    Cozzolongo, R.
    Mottola, L.
    Andriulli, A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 31 (12) : 1346 - 1353
  • [40] Comparison of a 6-month course peginterferon α-2b plus ribavirin and interferon α-2b plus ribavirin in treating Chinese patients with chronic hepatitis C in Taiwan
    Lee, SD
    Yu, ML
    Cheng, PN
    Lai, MY
    Chao, YC
    Hwang, SJ
    Chang, WY
    Chang, TT
    Hsieh, TY
    Liu, CJ
    Chen, DS
    JOURNAL OF VIRAL HEPATITIS, 2005, 12 (03) : 283 - 291
12345